Perspective Therapeutics (CATX) announced that its Board of Directors has appointed Maya Martinez-Davis as an independent director to the Company’s Board of Directors, effective today. Martinez-Davis currently serves as President of GSK‘s (GSK) U.S. Commercial business, a position she has held since September 2019.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CATX:
- Perspective Therapeutics Updates on Radiopharmaceutical Advancements
- Promising Clinical Pipeline and Strategic Investments Justify Buy Rating for Perspective Therapeutics
- Perspective Therapeutics Reports Q2 2025 Progress and Financials
- Positive Outlook for Perspective Therapeutics: Buy Rating Driven by Promising Clinical Developments and Strategic Progress
- Perspective Therapeutics Reports Promising Study Results at ASCO